3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Lymphoid
1
Gastrointestinal
1
Endocrine
1
Conditions
Neuroendocrine Tumors
6
Gastro-enteropancreatic neuroendocrine tumor
3
Carcinoid Tumor
2
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Pituitary ACTH Hypersecretion
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, Follicular
1
Liver Neoplasms
1
Hypoglycemia
1
Dumping Syndrome
1
Carcinoma
1
Adenoma, Islet Cell
1
Acromegaly
1
Interventions
pasireotide
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
pasireotide
×
NET
×
Clear all
NCT06784752
2026-04-30
NETTER-3
Novartis
Phase 3
Recruiting
240 enrolled